Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)
Saudi Arabia · Delayed Price · Currency is SAR 142.00
+0.40 (0.28%)
Aug 13, 2026, 3:10 PM AST
TADAWUL:4015 Revenue
Jamjoom Pharmaceuticals Factory Company had revenue of 445.31M SAR in the quarter ending June 30, 2026, with 12.39% growth. This brings the company's revenue in the last twelve months to 1.57B, up 9.20% year-over-year. In the year 2025, Jamjoom Pharmaceuticals Factory Company had annual revenue of 1.50B with 13.82% growth.
Revenue (ttm)
1.57B
Revenue Growth
+9.20%
P/S Ratio
6.29
Revenue / Employee
n/a
Employees
n/a
Market Cap
9.91B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.50B | 182.15M | 13.82% |
| Dec 31, 2024 | 1.32B | 217.66M | 19.77% |
| Dec 31, 2023 | 1.10B | 184.15M | 20.09% |
| Dec 31, 2022 | 916.67M | 180.99M | 24.60% |
| Dec 31, 2021 | 735.68M | -69.63M | -8.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.